BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24199958)

  • 1. Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function.
    Birdsill AC; Koscik RL; Jonaitis EM; Johnson SC; Okonkwo OC; Hermann BP; Larue A; Sager MA; Bendlin BB
    Neurobiol Aging; 2014 Apr; 35(4):769-76. PubMed ID: 24199958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
    Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
    J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants.
    Brugulat-Serrat A; Salvadó G; Operto G; Cacciaglia R; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Sánchez-Benavides G; Gramunt N; Minguillon C; Fauria K; Barkhof F; Molinuevo JL; Gispert JD;
    Hum Brain Mapp; 2020 Apr; 41(5):1309-1322. PubMed ID: 31778002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment.
    Arvanitakis Z; Fleischman DA; Arfanakis K; Leurgans SE; Barnes LL; Bennett DA
    Brain Struct Funct; 2016 May; 221(4):2135-46. PubMed ID: 25833685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White Matter Hyperintensities and Apolipoprotein E Affect the Association Between Mean Arterial Pressure and Objective and Subjective Cognitive Functioning in Older Adults.
    Jung Y; Viviano RP; van Rooden S; van der Grond J; Rombouts SARB; Damoiseaux JS
    J Alzheimers Dis; 2021; 84(3):1337-1350. PubMed ID: 34657884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
    Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
    Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.
    Yoshita M; Fletcher E; Harvey D; Ortega M; Martinez O; Mungas DM; Reed BR; DeCarli CS
    Neurology; 2006 Dec; 67(12):2192-8. PubMed ID: 17190943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracting and summarizing white matter hyperintensities using supervised segmentation methods in Alzheimer's disease risk and aging studies.
    Ithapu V; Singh V; Lindner C; Austin BP; Hinrichs C; Carlsson CM; Bendlin BB; Johnson SC
    Hum Brain Mapp; 2014 Aug; 35(8):4219-35. PubMed ID: 24510744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOE ε4 and risk for Alzheimer's disease: do regionally distributed white matter hyperintensities play a role?
    Brickman AM; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Provenzano FA; Narkhede A; Razlighi Q; Collins-Praino L; Artero S; Akbaraly TN; Ritchie K; Mayeux R; Portet F
    Alzheimers Dement; 2014 Nov; 10(6):619-29. PubMed ID: 25304991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral small vessel disease in aging and Alzheimer's disease: a comparative study using MRI and SPECT.
    Makedonov I; Black SE; MacIntosh BJ
    Eur J Neurol; 2013 Feb; 20(2):243-50. PubMed ID: 22742818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Chen YF; Wang H; Chu Y; Huang YC; Su MY
    Dement Geriatr Cogn Disord; 2006; 22(2):177-84. PubMed ID: 16912479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial patterns of white matter hyperintensities associated with Alzheimer's disease risk factors in a cognitively healthy middle-aged cohort.
    Salvadó G; Brugulat-Serrat A; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Fauria K; Cardoso MJ; Barkhof F; Molinuevo JL; Gispert JD;
    Alzheimers Res Ther; 2019 Jan; 11(1):12. PubMed ID: 30678723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
    Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
    Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.
    Brickman AM; Zahodne LB; Guzman VA; Narkhede A; Meier IB; Griffith EY; Provenzano FA; Schupf N; Manly JJ; Stern Y; Luchsinger JA; Mayeux R
    Neurobiol Aging; 2015 Jan; 36(1):27-32. PubMed ID: 25155654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between magnetic resonance imaging measures and neuropsychological impairment in early and late onset alzheimer's disease.
    van der Vlies AE; Staekenborg SS; Admiraal-Behloul F; Prins ND; Barkhof F; Vrenken H; Reiber JH; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2013; 35(1):169-78. PubMed ID: 23364136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer's disease.
    Gaubert M; Lange C; Garnier-Crussard A; Köbe T; Bougacha S; Gonneaud J; de Flores R; Tomadesso C; Mézenge F; Landeau B; de la Sayette V; Chételat G; Wirth M
    Alzheimers Res Ther; 2021 Jan; 13(1):29. PubMed ID: 33461618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.